Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration
暂无分享,去创建一个
M. Huestis | R. Vandrey | Ryan Vandrey | Garry Milman | Dayong Lee | Mateus Bergamaschi | Damodara R. Mendu | Jeannie A. Murray | Allan J. Barnes | Marilyn A. Huestis | D. R. Mendu | G. Milman | Dayong Lee | M. Bergamaschi | Jeannie A Murray
[1] Marilyn A Huestis,et al. Cannabis effects on driving skills. , 2013, Clinical chemistry.
[2] Reese T. Jones,et al. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users. , 1992, Journal of analytical toxicology.
[3] O. Drummer. Review: Pharmacokinetics of illicit drugs in oral fluid. , 2005, Forensic science international.
[4] J. Ramaekers,et al. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. , 2007, Journal of analytical toxicology.
[5] Charles J DiMaggio,et al. Marijuana use and motor vehicle crashes. , 2012, Epidemiologic reviews.
[6] Marilyn A Huestis,et al. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. , 2012, Journal of analytical toxicology.
[7] M. Huestis,et al. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. , 2011, Clinical chemistry.
[8] D. Kuntz,et al. Detection of THCA in oral fluid by GC-MS-MS. , 2006, Journal of analytical toxicology.
[9] M. Stitzer,et al. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. , 2013, Drug and alcohol dependence.
[10] W. Hall,et al. Testing for cannabis in the work-place: a review of the evidence. , 2010, Addiction.
[11] D. Kelly,et al. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. , 2009, Clinical chemistry.
[12] M. Huestis,et al. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. , 2010, Journal of chromatography. A.
[13] D. Kelly,et al. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. , 2010, Clinical chemistry.
[14] Matt Anderson,et al. European Monitoring Centre for Drugs and Drug Addiction , 2014 .
[15] M. Huestis,et al. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. , 2011, Clinical chemistry.
[16] M. Huestis,et al. Cannabinoid disposition in oral fluid after controlled smoked cannabis. , 2012, Clinical chemistry.
[17] E. Gallardo,et al. Current technologies and considerations for drug bioanalysis in oral fluid. , 2009, Bioanalysis.
[18] M R Moeller,et al. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. , 2006, Drug and alcohol dependence.
[19] George W Rebok,et al. Drug violations and aviation accidents: findings from the US mandatory drug testing programs. , 2011, Addiction.
[20] D. Kelly,et al. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. , 2011, Clinical chemistry.
[21] J. Hirvonen,et al. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. , 2011, Clinical chemistry.
[22] R. Frances. Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2013 .
[23] M. Huestis,et al. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? , 2013, Drug and alcohol dependence.
[24] L. Martens,et al. Review: The physiology of saliva and transfer of drugs into saliva. , 2005, Forensic science international.
[25] J. Ramaekers,et al. Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. , 2010, Journal of analytical toxicology.
[26] M. Huestis,et al. Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. , 2007, Journal of chromatography. A.
[27] Marilyn A Huestis,et al. Oral fluid testing for drugs of abuse. , 2009, Clinical chemistry.
[28] A. Verstraete,et al. Relationship Between Oral Fluid and Blood Concentrations of Drugs of Abuse in Drivers Suspected of Driving Under the Influence of Drugs , 2009, Therapeutic drug monitoring.
[29] A. Smith,et al. Cannabis use, cognitive performance and mood in a sample of workers , 2006, Journal of psychopharmacology.
[30] J. Ramaekers,et al. Dose related risk of motor vehicle crashes after cannabis use. , 2004, Drug and alcohol dependence.
[31] M. Huestis. Cannabis ( Marijuana ) — Effects on Human Behavior and Performance , 2002 .
[32] N. Samyn,et al. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users , 2000, International Journal of Legal Medicine.
[33] M. Huestis,et al. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. , 1992, Journal of analytical toxicology.